Rechallenge of ponatinib in chronic myeloid leukaemia after hepatotoxicity
Boo, Y L, Liam, C C K, Toh, S G, Lim, S M
Published in Hong Kong medical journal = Xianggang yi xue za zhi (01.04.2019)
Published in Hong Kong medical journal = Xianggang yi xue za zhi (01.04.2019)
Get full text
Journal Article
Fluctuation of BCR-ABL1 qPCRIS level beyond 0.1%IS after stopping tyrosine kinase inhibitor in chronic myeloid leukaemia patients with deep molecular response for at least two years
Kuan, J W, Chang, K M, Phan, C L, Wong, S P, Lim, S M, Toh, S G, Loh, W K
Published in Medical journal of Malaysia (01.05.2021)
Get full text
Published in Medical journal of Malaysia (01.05.2021)
Journal Article
Fluctuation of BCR-ABL1 qPCR IS level beyond 0.1% IS after stopping tyrosine kinase inhibitor in chronic myeloid leukaemia patients with deep molecular response for at least two years
Kuan, J W, Chang, K M, Phan, C L, Wong, S P, Lim, S M, Toh, S G, Loh, W K
Published in Medical journal of Malaysia (01.05.2021)
Get full text
Published in Medical journal of Malaysia (01.05.2021)
Journal Article
Rechallenge of ponatinib in chronic myeloid leukaemia after hepatotoxicity
Boo, Y L, Liam, Christopher CK, Toh, S G, Lim, S M
Published in Hong Kong medical journal = Xianggang yi xue za zhi (01.04.2019)
Published in Hong Kong medical journal = Xianggang yi xue za zhi (01.04.2019)
Get full text
Journal Article